240 participants
Safety and Immunogenicity of Two Doses of Monovalent Inactivated Influenza Vaccine That is Adjuvanted With MF59C.1 (MF59) and Uses a Surface Antigen From a Potential Pandemic Virus Strain Candidate (H5N1) in Adult and Elderly Subjects Using Four Different Vaccination Schedules
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2016-12-01
- Start Date:
- 2008-11-30
- Completion:
- 2009-06-30
Conditions
- Pre-pandemic Influenza Vaccine
Interventions
- BIOLOGICAL
No Results Yet